MGTX today
$9.18+$0.39 (+4.44%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minSymmetric Triangle
5 minStrong Bullish
Daily trend turns up above $9.99
Key levels
Resistance$9.99
Resistance$9.20
Support$8.44
Support$7.85
Latest news & SEC filings
EarningsMeiraGTx Posts Q3 2026 Results
SEC FilingMeiraGTx Holdings plc filed an automatic shelf registration for future offerings (Form S-3ASR)
EarningsMeiraGTx third-quarter loss per share $0.53, revenue $4.814M, both below estimates
SEC FilingMeiraGTx Holdings plc filed a report on a major company event (Form 8-K)
All MGTX news →About MeiraGTx
MeiraGTx is a clinical-stage genetic medicines company developing gene therapies for both inherited and more common disorders. Its programs target salivary gland damage from cancer treatment, a neurodegenerative movement disorder, and inherited vision loss, using localized delivery of viral vectors. The company also works on a gene regulation platform for metabolic peptides and cell-based treatments. It owns manufacturing sites in the United Kingdom and Ireland and partners with Johnson & Johnson, Eli Lilly, and Hologen.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
MeiraGTx Holdings plc (MGTX)
What Is the Price Target for MGTX?
SEPT Low Target
$16.00
SEPT Mid Target
$19.00
SEPT High Target
$30.00
Analyst Consensus
$19.00
Is MGTX a Buy or Sell Right Now?
Thesis
- •Revenue growing 144.6% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MGTX.
Start Free Trial →Is MGTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$15.57
38
Moat Score
NONE
3/9
Piotroski Score
-4.1
Altman Z-Score
What Is Smart Money Doing with MGTX?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Giroux Richard | officer | Sale | 56,000 | $557K | Oct 20, 2026 |
| Naylor Stuart | officer | Sale | 27,659 | $294K | Oct 6, 2026 |
| Giroux Richard | officer | Sale | 7,000 | - | May 27, 2026 |
| Forbes Alexandria | director officer | Sale | 62,000 | $569K | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MGTX Growth Story
Revenue YoY
144.6%
3yr Revenue CAGR
72.3%
EPS Growth YoY
33.02%
FCF Growth YoY
54.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for MGTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MGTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:52:18 | $9.09 | 5,000 | $$45K | BUY |
| 17:37:43 | $9.13 | 1,192 | $$11K | BUY |
| 17:36:18 | $9.13 | 1,200 | $$11K | MIDPOINT |
| 17:36:18 | $9.13 | 1,200 | $$11K | MIDPOINT |
| 17:35:17 | $9.14 | 1,200 | $$11K | BUY |
5 dark pool trades shown · $$89K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MeiraGTx Holdings plc (MGTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MGTX — frequently asked questions
What is MGTX stock price today?
MeiraGTx Holdings plc (MGTX) is at $9.18, up 4.44% (+$0.39) at the Nov 13, 2026 close.
Why is MGTX stock up today?
Nov 12, 2026: MeiraGTx shares fell 3.72% to close at $8.79 after the company reported third-quarter results that missed analyst estimates, with a loss of $0.53 per share versus the expected $0.50 and revenue of $4.814 million falling short of the $6.953 million estimate. The stock traded in a wide range between $9.70 and $8.77 on volume of about 1.36 million shares.
What is the MGTX price target?
The average analyst price target for MGTX is $19.00, ranging from $16 to $30, based on 6 analysts. Latest: Goldman Sachs initiates on Sep 24, 2026.
What do analysts rate MGTX?
Analyst ratings for MGTX: 0 Buy, 10 Hold, 0 Sell — consensus Hold.
Did MGTX beat earnings?
MGTX last reported on Nov 12, 2026: EPS -$0.53 vs -$0.50 expected — a miss of 6.0%.
What is MGTX's P/E ratio?
MGTX trades at a P/E of 13.6 vs a Healthcare average of 17.7.
Does MGTX pay a dividend?
MGTX does not currently pay a dividend.
What are MGTX support and resistance levels?
Support: $8.44, $7.85, $7.16. Resistance: $9.20, $9.99, $10.59.
What are insiders doing with MGTX?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on MGTX?
Nov 12, 2026: MeiraGTx Posts Q3 2026 Results · Nov 12, 2026: MeiraGTx Holdings plc filed an automatic shelf registration for future offerings (Form S-3ASR) · Nov 12, 2026: MeiraGTx third-quarter loss per share $0.53, revenue $4.814M, both below estimates